Status:

COMPLETED

Emergence of Gram-negative Resistance in Blood Culture Isolates of Solid-organ Transplant Recipients

Lead Sponsor:

University of Pittsburgh

Conditions:

Gram Negative Infection

Eligibility:

All Genders

Brief Summary

The information collected will provide insight in to the epidemiology of antibiotic resistance in a transplant compared to a non-transplant population. Data is needed regarding the date of admission, ...

Detailed Description

We need to collect details on the demographics (age, sex etc), underlying conditions, transplant types and immunosuppression, in-hospital antibiotic management and clinical outcomes so that the effect...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • All patients with a positive blood culture isolate growing a gram-negative organism will be included from 1996 - 2005

Exclusion

    Key Trial Info

    Start Date :

    September 1 2006

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    June 1 2017

    Estimated Enrollment :

    1000 Patients enrolled

    Trial Details

    Trial ID

    NCT00304330

    Start Date

    September 1 2006

    End Date

    June 1 2017

    Last Update

    June 12 2018

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania, United States, 15213